CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study

被引：0
|
作者：
Lanzo, G. [1 ]
Borghese, G. [1 ]
Arisio, R. [1 ]
Katsaros, D. [1 ]
Volante, M. [2 ]
Rapa, I. [2 ]
Benedetto, C. [1 ]
Ortolan, E. [3 ]
Funaro, A. [3 ]
机构：
[1] Univ Turin, St Anna Hosp, Dept Obstet & Gynaecol, I-10124 Turin, Italy
[2] Univ Turin, San Luigi Hosp, Dept Pathol, I-10124 Turin, Italy
[3] Univ Turin, Dept Immunogenet, I-10124 Turin, Italy
来源：
REPRODUCTIVE SCIENCES | 2014年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：208A / 209A
页数：2
相关论文
共 50 条
  • [21] Defining microRNA mediated regulation of CD157 involved in colon cancer progression
    Damavandi, Mahnaz Darvish
    Vlachogiannis, George
    Nyamundanda, Gift
    Lampis, Andrea
    Parkes, Harold
    Hedayat, Somaieh
    Hahne, Jens
    Fassan, Matteo
    Sadanandam, Anguraj
    Sansom, Owen
    Valeri, Nicola
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 21 - 22
  • [22] An immature rat lymphocyte marker CD157: Striking differences in the expression between mice and rats
    Seki, M
    Fairchild, S
    Rosenwasser, OA
    Tada, N
    Tomonari, K
    IMMUNOBIOLOGY, 2001, 203 (05) : 725 - 742
  • [23] The Eag potassium channel as a new prognostic marker in ovarian cancer
    Asher, Viren
    Khan, Raheela
    Warren, Averil
    Shaw, Robert
    Schalkwyk, Gerhard V.
    Bali, Anish
    Sowter, Heidi M.
    DIAGNOSTIC PATHOLOGY, 2010, 5
  • [24] The Eag potassium channel as a new prognostic marker in ovarian cancer
    Viren Asher
    Raheela Khan
    Averil Warren
    Robert Shaw
    Gerhard V Schalkwyk
    Anish Bali
    Heidi M Sowter
    Diagnostic Pathology, 5
  • [25] An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator
    Haruhiro Higashida
    Mingkun Liang
    Toru Yoshihara
    Shirin Akther
    Azam Fakhrul
    Cherepanov Stanislav
    Tae-Sik Nam
    Uh-Hyun Kim
    Satoka Kasai
    Tomoko Nishimura
    Naila Al Mahmuda
    Shigeru Yokoyama
    Katsuhiko Ishihara
    Maria Gerasimenko
    Alla Salmina
    Jing Zhong
    Takahiro Tsuji
    Chiharu Tsuji
    Olga Lopatina
    BMC Neuroscience, 18
  • [26] Pathological Chemotherapy Response Score as a Prognostic Marker in Ovarian Cancer: A Retrospective Analysis
    Kim, Teresa
    Kubalanza, Kari
    Konecny, Gottfried
    Rao, Jianyu
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1082 - 1083
  • [27] Pathological Chemotherapy Response Score as a Prognostic Marker in Ovarian Cancer: A Retrospective Analysis
    Kim, Teresa
    Kubalanza, Kari
    Konecny, Gottfried
    Rao, Jianyu
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1082 - 1083
  • [28] CD133 is an independent predictive and prognostic marker in metastatic breast cancer
    Hefni, Ahmed Mubarak
    Sayed, Ayat Mohammed
    Hussien, Marwa T.
    Abdalla, Ashraf Zeidan
    Gabr, Adel Gomaa
    CANCER BIOMARKERS, 2022, 35 (02) : 207 - 215
  • [29] An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator
    Higashida, Haruhiro
    Liang, Mingkun
    Yoshihara, Toru
    Akther, Shirin
    Fakhrul, Azam
    Stanislav, Cherepanov
    Nam, Tae-Sik
    Kim, Uh-Hyun
    Kasai, Satoka
    Nishimura, Tomoko
    Al Mahmuda, Naila
    Yokoyama, Shigeru
    Ishihara, Katsuhiko
    Gerasimenko, Maria
    Salmina, Alla
    Zhong, Jing
    Tsuji, Takahiro
    Tsuji, Chiharu
    Lopatina, Olga
    BMC NEUROSCIENCE, 2017, 18
  • [30] CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu, Pina
    Pretta, Andrea
    Aimola, Valentina
    Cau, Flaviana
    Mariani, Stefano
    D'Agata, Alessandra Pia
    Codipietro, Claudia
    Rizzo, Daiana
    Dell'Utri, Veronica
    Sanna, Giorgia
    Moledda, Giusy
    Cadoni, Andrea
    Lai, Eleonora
    Puzzoni, Marco
    Pusceddu, Valeria
    Castagnola, Massimo
    Scartozzi, Mario
    Faa, Gavino
    CANCERS, 2024, 16 (08)
12345